Serum Amyloid A in Stable Patients with Chronic Obstructive Pulmonary Disease Does Not Reflect the Clinical Course of the Disease

Serum amyloid A (SAA) is a good systemic marker of the exacerbations of chronic obstructive pulmonary disease (COPD), but the significance of SAA in stable patients with COPD has not been widely investigated. We aimed to evaluate the SAA level in peripheral blood from stable patients with COPD and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Maskey-Warzęchowska, Marta, Rubinsztajn, Renata, Przybyłowski, Tadeusz, Karwat, Krzysztof, Nejman-Gryz, Patrycja, Paplińska-Goryca, Magdalena, Chazan, Ryszarda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916457/
https://www.ncbi.nlm.nih.gov/pubmed/36768801
http://dx.doi.org/10.3390/ijms24032478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916457/
https://www.ncbi.nlm.nih.gov/pubmed/36768801
http://dx.doi.org/10.3390/ijms24032478

Ejemplares similares